Literature DB >> 16706793

Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.

Minoru Ohama1, Kazufumi Hiramatsu, Yoshiko Miyajima, Kenji Kishi, Masaru Nasu, Jun-ichi Kadota.   

Abstract

We examined the protective effect of intratracheal immunization with Pseudomonas aeruginosa pili protein against respiratory infection caused by P. aeruginosa. Mice were immunized intratracheally or subcutaneously with purified pili protein or bovine serum albumin as a control. Intratracheally but not subcutaneously pili protein-immunized mice showed significant improvement of survival after intratracheal challenge with the PAO1 strain. Furthermore, bacterial cell counts in pili protein-immunized murine lungs were significantly decreased compared to controls at 18 h after the challenge. Antipili protein antibody titers in bronchoalveolar lavage fluid of intratracheally pili protein-immunized mice were higher than in bovine serum albumin immunized mice. However, antipili antibody titers were not increased in bronchoalveolar lavage fluid of subcutaneously pili protein-immunized mice, despite the high serum antipili antibody titers. Inoculation of P. aeruginosa induced immediate increases in interleukin-12 and interferon-gamma in bronchoalveolar lavage fluid of pili protein-immunized mice, reflecting an adequate and rapid immune response against P. aeruginosa respiratory tract infection. Our findings suggest that intratracheal pili protein immunization is effective against respiratory tract infection caused by P. aeruginosa in mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706793     DOI: 10.1111/j.1574-695X.2006.00069.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  10 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

Review 2.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

3.  Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244.

Authors:  Mohammed Qutyan; Matthew Henkel; Joseph Horzempa; Michael Quinn; Peter Castric
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

4.  Evolution of Pseudomonas aeruginosa type III secretion in cystic fibrosis: a paradigm of chronic infection.

Authors:  Manu Jain; Maskit Bar-Meir; Susanna McColley; Joanne Cullina; Eileen Potter; Cathy Powers; Michelle Prickett; Roopa Seshadri; Borko Jovanovic; Argyri Petrocheilou; John D King; Alan R Hauser
Journal:  Transl Res       Date:  2008-10-31       Impact factor: 7.012

5.  Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection.

Authors:  Joseph Horzempa; Thomas K Held; Alan S Cross; Dana Furst; Mohammed Qutyan; Alice N Neely; Peter Castric
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

Review 6.  Pseudomonas aeruginosa virulence and therapy: evolving translational strategies.

Authors:  Jeffrey L Veesenmeyer; Alan R Hauser; Thiago Lisboa; Jordi Rello
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

7.  Construction, expression, purification and characterization of secretin domain of PilQ and triple PilA-related disulfide loop peptides fusion protein from Pseudomonas aeruginosa.

Authors:  Sobhan Faezi; Ahmad Reza Bahrmand; Seyed Davar Siadat; Iraj Nikokar; Soroush Sardari; Mehdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2017-05       Impact factor: 2.699

8.  PA0833 Is an OmpA C-Like Protein That Confers Protection Against Pseudomonas aeruginosa Infection.

Authors:  Feng Yang; Jiang Gu; Jintao Zou; Langhuan Lei; Haiming Jing; Jin Zhang; Hao Zeng; Quanming Zou; Fenglin Lv; Jinyong Zhang
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

Review 9.  Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Authors:  Maite Sainz-Mejías; Irene Jurado-Martín; Siobhán McClean
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

10.  Development of a Novel Anti-Adhesive Vaccine Against Pseudomonasaeruginosa Targeting the C-terminal Disulfide Loop of the Pilin Protein.

Authors:  Sobhan Faezi; Ahmad Reza Bahrmand; Mehdi Mahdavi; Seyed Davar Siadat; Iraj Nikokar; Soroush Sardari
Journal:  Int J Mol Cell Med       Date:  2017-05-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.